Acrolein: Excessive cytotoxicity or potent mutagenicity?

Chemical Research in Toxicology

Volumn 22, Issue 5, 2009, Pages 751-753

  Besaratinia, Ahmad ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACROLEIN;

BIOTRANSFORMATION; CYTOTOXICITY; DNA MODIFICATION; GENE MUTATION; HUMAN; INCUBATION TIME; LETTER; LUNG CANCER; MUTAGENESIS; NONHUMAN; OXIDATION;

ACROLEIN; DNA ADDUCTS; DNA DAMAGE; MUTAGENS; MUTATION;

EID: 67649921387     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx900098u     Document Type: Letter

References (16)

1. Wang, H. T., Zhang, S., Hu, Y., and Tang, M. S. (2009) Mutagenicity and sequence specificity of acrolein-DNA adducts. Chem. Res. Toxicol. 22, 511-517.
2. Feng, Z., Hu, W., Hu, Y., and Tang, M. S. (2006) Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc. Natl. Acad. Sci. U.S.A. 103, 15404-15409.
3. Feron, V. J., Til, H. P., de Vrijer, F., Woutersen, R. A., Cassee, F. R., and van Bladeren, P. J. (1991) Aldehydes: Occurrence, carcinogenic potential, mechanism of action and risk assessment. Mutat. Res. 259, 363-385.
4. Ghilarducci, D. P., and Tjeerdema, R. S. (1995) Fate and effects of acrolein. Rev. Environ. Contam. Toxicol. 144, 95-146.
5. Kehrer, J. P., and Biswal, S. S. (2000) The molecular effects of acrolein. Toxicol. Sci. 57, 6-15.
6. Kim, S. I., Pfeifer, G. P., and Besaratinia, A. (2007) Lack of mutagenicity of acrolein-induced DNA adducts in mouse and human cells. Cancer Res. 67, 11640-11167.
7. Nath, R. G., Chen, H. J., Nishikawa, A., Young-Sciame, R., and Chung, F. L. (1994) A 32P-postlabeling method for simultaneous detection and quantification of exocyclic etheno and propano adducts in DNA. Carcinogenesis 15, 979-984.
8. Zhang, S., Villalta, P. W., Wang, M., and Hecht, S. S. (2007) Detection and quantitation of acrolein-derived 1, N2-propanodeoxyguanosine adducts in human lung by liquid chromatography-electrospray ionization-tandem mass spectrometry. Chem. Res. Toxicol. 20, 565-571.
9. Yang, I. Y., Hossain, M., Miller, H., Khullar, S., Johnson, F., Grollman, A., and Moriya, M. (2001) Responses to the major acrolein-derived deoxyguanosine adduct in Escherichia coli. J. Biol. Chem. 276, 9071-9076.
10. Yang, I. Y., Johnson, F., Grollman, A. P., and Moriya, M. (2002) Genotoxic mechanism for the major acrolein-derived deoxyguanosine adduct in human cells. Chem. Res. Toxicol. 15, 160-164.
11. Yang, I. Y., Chan, G., Miller, H., Huang, Y., Torres, M. C., Johnson, F., and Moriya, M. (2002) Mutagenesis by acrolein-derived propanodeoxyguanosine adducts in human cells. Biochemistry 41, 13826-13832.
12. Kanuri, M., Minko, I. G., Nechev, L. V., Harris, T. M., Harris, C. M., and Lloyd, R. S. (2002) Error prone translesion synthesis past gamma-hydroxypropano deoxyguanosine, the primary acrolein-derived adduct in mammalian cells. J. Biol. Chem. 277, 18257-18265.
13. Sanchez, A. M., Minko, I. G., Kurtz, A. J., Kanuri, M., Moriya, M., and Lloyd, R. S. (2003) Comparative evaluation of the bioreactivity and mutagenic spectra of acrolein-derived alpha-HOPdG and gamma-HOPdG regioisomeric deoxyguanosine adducts. Chem. Res. Toxicol. 16, 1019-1028.
14. VanderVeen, L. A., Hashim, M. F., Nechev, L. V., Harris, T. M., Harris, C. M., and Marnett, L. J. (2001) Evaluation of the mutagenic potential of the principal DNA adduct of acrolein. J. Biol. Chem. 276, 9066-9070.
15. Yang, I. Y., Miller, H., Wang, Z., Frank, E. G., Ohmori, H., Hanaoka, F., and Moriya, M. (2003) Mammalian translesion DNA synthesis across an acrolein-derived deoxyguanosine adduct. Participation of DNA polymerase eta in error-prone synthesis in human cells. J. Biol. Chem. 278, 13989-13994.
16. IARC (1995) Acrolein. IARC Monogr. Eval. Carcinog. Risks Hum. 63, 337-372.